Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA
Clinical trial NCT06095388 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06095388
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-04
- Primary completion
- 2029-10-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.